EGR2 and gastric cancer: In this study, we systematically delineated the transcriptional regulatory landscape of THY1 in gastric cancer by identifying six robust putative regulators—PRRX1, TWIST1, SNAI2, MEIS3, VENTX, and EGR2—through an integrative multicohort approach.